Latin America Sleep Apnea Devices Market

Latin America Sleep Apnea Devices Market Size (2023 to 2028)

The size of the Latin American Sleep Apnea Devices Market was worth USD 0.99 billion in 2023 and is expected to grow at a CAGR of 6.9% and value USD 1.39 billion by 2028. Latin America is the quickest growing region in the global sleep apnea devices market. It represents 12% of the global sleep apnea devices market.

When the airway is blocked during sleep, it causes sleep Apnea. It has many negative effects if left untreated. Some of those effects are hypertension, cardiovascular diseases, impotence, etc. The main cause of the problem is oxygen deficiency. It also distorts the sleep cycle as the person is jerked awake because of the reflex action of the brain to heightened carbon dioxide levels. Sleepiness and tiredness are a few symptoms of this disease. Several medical devices are used for the treatment of this disease.

Factors such as rising obesity problems, increasing chronic diseases, and advanced technologies in improving the techniques for better treatment propelling the market growth. Also, growing knowledge related to hypertension and working for long hours are the factors boosting the market. Growing awareness regarding hypertension and other prevalent chronic diseases, rapid advancements in technology resulting in the development of enhanced and improved treatment techniques, high stress, long working hours, and increasing cases of depression and obesity are the key factors contributing to high market growth.

However, expensive treatment procedures and high discomfort are inhibiting the growth of this market. The cost of these devices is expensive, long-term use of sleep apnea devices may be difficult for the users, which are some factors restraining the market growth. Moreover, the lack of awareness among people is also limiting the market.

This research report on the Latin America Sleep Apnea Devices Market has been segmented and sub-segmented into the following categories:

By Diagnostic Devices: 

• Polysomnography Devices     
  • Ambulatory PSG Devices     
  • Clinical PSG Devices  
• Respiratory Polygraphs
• Oximeters
  • Single-Channel Screening Devices (Pulse Oximeters)   
  • Fingertip Pulse Oximeters    
  • Handheld Pulse Oximeters    
  • Wrist-Worn Pulse Oximeters  
  • Tabletop Pulse Oximeters    
• Actigraphy Systems 

By Therapeutic Devices: 

• Positive Airway Pressure (PAP) Devices
  • CPAP Devices
  • APAP Devices
  • BPAP Devices
• Facial Interfaces       
  • Masks
    • Nasal Masks
    • Nasal Pillow Masks
    • Full-Face Masks
• Adaptive Servo-Ventilation Instruments (ASV)  
• Airway Clearance Systems     
• Oxygen Concentrators
  • Stationary Concentrators     
  • Portable Concentrators       
• Accessories   
  • Pillows       
  • Chin Restraints       
  • Mask Cleaning Wipes
  • Other Accessories    
• Oral Appliances
  • Mandibular Advancement Devices    
  • Tongue Retaining Devices

By Country: 

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

Regionally, the Latin American market occupied an estimated 12% of the global sleep apnea devices market share in 2022. However, the Mexican sleep apnea devices market size is likely to register with a CAGR value of 11.82% during the forecast period due to increased respiratory problems like TB, Asthma, and sleep apnea disorders.

KEY MARKET PLAYERS:

Companies such as ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other players in the market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), and Whole You, Inc. (U.S.), which are currently playing a leading role in the Latin American sleep apnea devices market and profiled in this report.